HealthNotableSingle-sourceDeveloping
5.6
GLP-1 receptor agonist adoption trends and clinical implications in US healthcare
Al Jazeera·US·1 day ago
The European Commission has authorized a prescription-only weight-loss pill for adults suffering from obesity or overweight conditions with weight-related comorbidities. The treatment requires mandatory medical supervision, marking a significant expansion of pharmacological options for obesity management in the EU market.